FIELD: medicine, ophthalmology, pharmacy.
SUBSTANCE: invention proposes a pharmaceutical composition used in treatment of cornea injuries that comprises, mas.p.p.: sodium deoxyribonucleate, 14-15; sodium chloride, 0.8-0.9; lyophilized blood plasma, 74-75, and distilled water, the balance. Components are mixed in aseptic conditions and packaged. Invention provides anti-inflammatory, antiviral, antibacterial, reparative and regenerative effect, decreasing treatment period and declining post-operative complications.
EFFECT: improved, enhanced and valuable medicinal properties of pharmaceutical composition.
2 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
DERINAT SUPPOSITORIES TO BE USED IN MEDICAL PRACTICE | 2009 |
|
RU2429854C2 |
METHOD FOR TREATING OPHTHALMIC MANIFESTATIONS OF DISEASES TRANSMITTED VIA SEXUAL INTERCOURSE | 2003 |
|
RU2259180C2 |
HYDROGEL COMPOSITION FOR TREATING BURNS | 2010 |
|
RU2438654C1 |
GEL-LIKE EYE DROPS FOR TREATMENT OF INFLAMMATORY ALLERGIC, BACTERIAL, VIRAL, TRAUMATIC AND DYSTROPHIC EYE DISEASES | 2014 |
|
RU2561046C1 |
METHOD FOR TREATING DESCEMENTOCELE | 1993 |
|
RU2090166C1 |
METHOD FOR TREATMENT OF CORNEA INJURIES | 1993 |
|
RU2090165C1 |
COMPOSITION FOR PREVENTING OR TREATING PROCTOLOGICAL DISEASES | 2022 |
|
RU2814279C2 |
SODIUM DEOXYRIBONUCLEATE SUPPOSITORIES, RECTAL AND VAGINAL | 2015 |
|
RU2601621C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING EYE DISEASES RELATED TO EYE TISSUE METABOLIC DISEASE AND INFLAMMATORY EYE TISSUE INJURY | 2013 |
|
RU2521337C1 |
SODIUM DEOXYRIBONUCLEATE, SUBLINGUAL ORODISPERSIBLE TABLETS AND METHOD OF THEIR OBTAINING | 2016 |
|
RU2651043C1 |
Authors
Dates
2008-04-20—Published
2006-10-20—Filed